Nan, D., C. Abraira-Meriel, S. de la Roz-Fernandez, T. Maestre-Orozco, J. L. Hernandez, and M. Fernandez-Ayala. “Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients With Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report”. European Journal of Case Reports in Internal Medicine, vol. 8, no. 10, Oct. 2021, doi:10.12890/2021_002821.